Tennessee is moving forward with clinical trials of ibogaine, a controversial psychedelic drug recently fast-tracked for research under an executive order signed by President Donald Trump. Tennessee ...
The US Food and Drug Administration (FDA) offered a framework for clinical investigations and drug development programs evaluating psychedelic drugs to treat medical conditions, such as substance use ...
The Food and Drug Administration granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. NBC News' Erika Edwards reports on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results